, Tracking Stock Market Picks
Enter Symbol:
Biomarin Pharmaceutical Inc. (BMRN) [hlAlert]

up 395.23 %

Biomarin Pharmaceutical Inc. (BMRN) rated Buy with price target $33 by Collins Stewart

Posted on: Friday,  Apr 29, 2011  8:25 AM ET by Collins Stewart

Collins Stewart rated Buy Biomarin Pharmaceutical Inc. (NASDAQ: BMRN) on 04/29/2011, when the stock price was $26.43. Since
then, Biomarin Pharmaceutical Inc. has gained 395.23% as of 11/25/2015's recent price of $130.89.
If you would have followed this Collins Stewart's recommendation on BMRN, you would have gained 395.23% of your investment in 1671 days.

BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans.

Collins Stewart's research department is built around a number of sector-specialist teams. Our analysts are leaders in their area of specialisation and combine deep industry knowledge with decades of stock broking experience to produce insightful, independent sector research. Our research approach encompasses Questâ„¢ principles and focuses on cash-driven valuation techniques. Research is a Collins Stewart cornerstone; it is leveraged throughout the organisation.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/29/2011 8:25 AM Buy
26.43 33.00
as of 12/30/2011
1 Week up  1.80 %
1 Month down  -0.69 %
3 Months up  7.87 %
1 YTD up  27.66 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/9/2009 8:25 AM Buy
17.06 22.00
2/19/2009 8:25 AM Hold
8/21/2008 12:25 PM Buy
25.83 39.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy